StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2023, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 28 Oct 2022 02:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Press+Releases/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html for the full story. http://www.streetinsider.com/Globe+Newswire/Quantum+Genomics+Announces+Lack+of+Significant+Efficacy+for+Firibastat+in+Their+Phase+III+Study%2C+FRESH+and+is+Redirecting+to+New+Developments/20759747.html Fri, 28 Oct 2022 02:00:00 -0400 A.00578948 A.32657771 ALQGC O.01150339 O.03260450 O.08573398 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Press+Releases/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Globe+Newswire/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Globe+Newswire/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share http://www.streetinsider.com/Globe+Newswire/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html for the full story. http://www.streetinsider.com/Globe+Newswire/Bryan+Garnier+%26amp%3B+Co+Initiates+the+Coverage+of+Quantum+Genomics+with+a+Target+Price+at+13%E2%82%AC+per+Share/20674897.html Thu, 06 Oct 2022 12:00:00 -0400 A.00578948 A.07275906 A.35619141 ALQGC O.00448667 O.03260450 O.08573398 O.31842592 QNNTF